Canada markets open in 3 hours 4 minutes

Regeneron Pharmaceuticals, Inc. (REGN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
937.61+34.13 (+3.78%)
At close: 04:00PM EDT
929.90 -7.71 (-0.82%)
Pre-Market: 04:38AM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 103.31B
Enterprise Value 95.49B
Trailing P/E 27.68
Forward P/E 20.75
PEG Ratio (5 yr expected) 1.50
Price/Sales (ttm)8.16
Price/Book (mrq)3.83
Enterprise Value/Revenue 7.28
Enterprise Value/EBITDA 20.35

Trading Information

Stock Price History

Beta (5Y Monthly) 0.14
52-Week Change 318.55%
S&P500 52-Week Change 321.33%
52 Week High 3998.33
52 Week Low 3684.81
50-Day Moving Average 3944.59
200-Day Moving Average 3866.61

Share Statistics

Avg Vol (3 month) 3463.1k
Avg Vol (10 day) 3470.84k
Shares Outstanding 5108.37M
Implied Shares Outstanding 6110.19M
Float 8102.77M
% Held by Insiders 11.69%
% Held by Institutions 188.99%
Shares Short (Apr 15, 2024) 41.39M
Short Ratio (Apr 15, 2024) 43.05
Short % of Float (Apr 15, 2024) 41.50%
Short % of Shares Outstanding (Apr 15, 2024) 41.26%
Shares Short (prior month Mar 15, 2024) 41.39M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 30.14%
Operating Margin (ttm)29.20%

Management Effectiveness

Return on Assets (ttm)8.49%
Return on Equity (ttm)16.26%

Income Statement

Revenue (ttm)13.12B
Revenue Per Share (ttm)122.93
Quarterly Revenue Growth (yoy)0.60%
Gross Profit (ttm)N/A
EBITDA 4.65B
Net Income Avi to Common (ttm)3.95B
Diluted EPS (ttm)34.77
Quarterly Earnings Growth (yoy)-3.10%

Balance Sheet

Total Cash (mrq)10.84B
Total Cash Per Share (mrq)100.92
Total Debt (mrq)2.79B
Total Debt/Equity (mrq)10.74%
Current Ratio (mrq)5.69
Book Value Per Share (mrq)242.47

Cash Flow Statement

Operating Cash Flow (ttm)4.59B
Levered Free Cash Flow (ttm)2.76B